Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 4 May 2026
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Reliance, Kotak Mahindra Bank, and Sun Pharma

Nifty 50 slips below 24,000: What are the key levels to watch for next week?
On April 30, Indian stock indices fell nearly 1% due to rising crude oil prices and foreign fund exits. The Nifty 50 and Sensex closed at 23,997.55 and 76,913.50, respectively. Despite this, both indices showed weekly gains, breaking previous losing streaks.
Will Sensex, Nifty rally after state election results? Here's why analysts advise caution
Kotak Institutional Equities says any election-driven market rally may be short-lived, as rising oil prices and a widening deficit pose bigger risks. While positive poll outcomes could lift sentiment briefly, escalating geopolitical tensions and surging crude are likely to shift focus back to macroeconomic pressures.
Benchmarks slide as crude climbs, Sensex sheds 583 pts, Nifty below 24K
Equity benchmark indices tumbled on Thursday as surging crude oil prices, weak Asian cues and relentless foreign fund outflows battered investor sentiment. The Nifty slipped below the 24,000 mark, weighed down by banking stocks. Most sectoral indices ended in the red, with the Nifty IT index bucking the trend. Brent crude climbed to around $120 per barrel amid rising fears of supply disruptions linked to potential curbs on Irans ports, fuelling inflation concerns in India. Global markets offered little support, pressured by elevated energy prices and uncertainty over the Federal Reserves policy stance. Meanwhile, a sharp slide in the rupee to a record low added to the strain on domestic equities.

Zerodha Nifty Smallcap 100 Share Price | NSE:ZERI ETF - Investing.com India
Zerodha Nifty Smallcap 100 Share Price | NSE:ZERI ETFInvesting.com India
Zerodha Nifty Smallcap 100 Share Price | NSE:ZERI ETF - Investing.com India
Zerodha Nifty Smallcap 100 Share Price | NSE:ZERI ETFInvesting.com India

Sensex Today | Stock Market Highlights: Sensex, Nifty end higher but off highs; midcaps underperform
Sensex Today | Stock Market Highlights: Benchmark indices ended higher on Wednesday but trimmed gains from intraday highs, with frontline stocks outperforming the broader market. The Sensex rose 609 points to close at 77,496, while the Nifty gained 182 points to settle above 24,150. Gains were led by ITC, Tech Mahindra, Reliance Industries, Maruti Suzuki and Coal India.
FIIs, MFs raise stake in these 10 microcaps; stock gains up to 75% in six months
FIIs and mutual funds raised stakes in 10 fast-rising microcaps from the Nifty 250 Microcap index, with stocks delivering up to 75% returns in six months.
Stock markets can deliver years of zero returns, explains DSP Mutual Fund MD, CEO: Key takeaways for investors - Mint
Stock markets can deliver years of zero returns, explains DSP Mutual Fund MD, CEO: Key takeaways for investorsMint

Stock markets can deliver years of zero returns, explains DSP Mutual Fund MD, CEO: Key takeaways for investors
Kalpen Parekh, MD and CEO at DSP Mutual Fund, shared an important insight in his post on social media platform X (formerly Twitter) that all markets can have long periods of zero returns.

Sensex Today | Stock Market Highlights: Nifty slips below 24,000; banks drag markets lower
Sensex Today | Stock Market Highlights: The indices ended largely in the red on Tuesday, with the Nifty slipping below the 24,000 mark amid weakness in banking stocks. The Sensex fell 417 points to close at 76,887, while the Nifty declined 97 points to settle at 23,996. The Nifty Bank index dropped 864 points to 55,400 as all constituents, barring Kotak Mahindra Bank, ended lower. PSU banks were among the worst hit, with the sectoral index falling 2% after the RBI finalised ECL norms.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.